Suppr超能文献

一篇评论:糖尿病视网膜病变的心理物理学评估。

A critical review: Psychophysical assessments of diabetic retinopathy.

机构信息

Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan.

Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan.

出版信息

Surv Ophthalmol. 2021 Mar-Apr;66(2):213-230. doi: 10.1016/j.survophthal.2020.08.003. Epub 2020 Aug 29.

Abstract

Diabetic retinal disease remains a leading cause of vision loss despite currently available screening methods, ocular treatments, and efforts to control metabolic dysfunction. It is now understood that diabetes damages the entire retina and the cellular components of the neurovascular unit. Multiple studies have demonstrated impairment of various aspects of retinal function across the spectrum of retinopathy severity. Here we review these tests, the principles underlying their use, clinical data from multiple publications, the strengths and limitations of the studies, and prospects for their application to understand the pathophysiology of diabetic retinal disease and monitor its response to therapy. We focus on visual acuity, contrast sensitivity, color vision, visual field, and dark adaptation and their use to understand the pathophysiology of diabetic retinopathy and as potential endpoints for clinical trials.

摘要

尽管目前有筛查方法、眼部治疗和控制代谢功能障碍的措施,糖尿病性视网膜病变仍然是导致视力丧失的主要原因。现在已经了解到,糖尿病会损害整个视网膜和神经血管单元的细胞成分。多项研究表明,在视网膜病变严重程度的范围内,视网膜功能的各个方面都受到了损害。在这里,我们回顾了这些检查,包括它们使用的原理、来自多个出版物的临床数据、研究的优缺点,以及将它们应用于了解糖尿病性视网膜病变的病理生理学和监测其对治疗的反应的前景。我们重点介绍了视力、对比敏感度、色觉、视野和暗适应及其在了解糖尿病性视网膜病变的病理生理学以及作为临床试验的潜在终点方面的应用。

相似文献

1
A critical review: Psychophysical assessments of diabetic retinopathy.
Surv Ophthalmol. 2021 Mar-Apr;66(2):213-230. doi: 10.1016/j.survophthal.2020.08.003. Epub 2020 Aug 29.
2
Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy.
Br J Ophthalmol. 2012 May;96(5):699-703. doi: 10.1136/bjophthalmol-2011-300467. Epub 2011 Dec 15.
3
Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.
Ophthalmology. 2015 May;122(5):957-67. doi: 10.1016/j.ophtha.2014.12.001. Epub 2015 Jan 17.
5
Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy.
Clin Exp Ophthalmol. 2016 Dec;44(9):838-852. doi: 10.1111/ceo.12795. Epub 2016 Aug 1.
6
Measuring retinal sensitivity with the microperimeter in patients with diabetes.
Retina. 2012 Jul;32(7):1302-9. doi: 10.1097/IAE.0b013e3182365a24.
7
Retinal sensitivity changes associated with diabetic neuropathy in the absence of diabetic retinopathy.
Br J Ophthalmol. 2017 Sep;101(9):1174-1178. doi: 10.1136/bjophthalmol-2016-309641. Epub 2017 Jan 20.
8
Frontiers in diabetic retinal disease.
J Diabetes Complications. 2023 Feb;37(2):108386. doi: 10.1016/j.jdiacomp.2022.108386. Epub 2022 Dec 21.
9
Disorganization of Retinal Inner Layers (DRIL) and Neuroretinal Dysfunction in Early Diabetic Retinopathy.
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5481-5486. doi: 10.1167/iovs.18-24955.

引用本文的文献

2
Clinical Applications of the Cone Contrast Test in Ophthalmology and Neurology.
J Clin Med. 2025 Apr 29;14(9):3079. doi: 10.3390/jcm14093079.
3
Ten years of visual field change in people living with diabetes: A prospective longitudinal study.
PLoS One. 2025 Mar 25;20(3):e0320285. doi: 10.1371/journal.pone.0320285. eCollection 2025.
4
The relationship between ON-OFF function and OCT structural and angiographic parameters in early diabetic retinal disease.
Ophthalmic Physiol Opt. 2025 Jan;45(1):77-88. doi: 10.1111/opo.13394. Epub 2024 Oct 14.
5
Clinical Evidence of a Photoreceptor Origin in Diabetic Retinal Disease.
Ophthalmol Sci. 2024 Aug 2;5(1):100591. doi: 10.1016/j.xops.2024.100591. eCollection 2025 Jan-Feb.
6
Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available Measures.
Ophthalmol Sci. 2024 Apr 6;4(5):100519. doi: 10.1016/j.xops.2024.100519. eCollection 2024 Sep-Oct.
8
Achromatic and chromatic contrast discrimination in patients with type 2 diabetes.
Sci Rep. 2023 May 8;13(1):7420. doi: 10.1038/s41598-023-34407-1.
10
Contrast Increment and Decrement Processing in Individuals With and Without Diabetes.
Invest Ophthalmol Vis Sci. 2023 Apr 3;64(4):26. doi: 10.1167/iovs.64.4.26.

本文引用的文献

1
Treated PDR Reveals Age-Appropriate Vision Deterioration But Distorted Retinal Organization.
Transl Vis Sci Technol. 2020 Feb 7;9(3):3. doi: 10.1167/tvst.9.3.3.
3
Patient-Reported Outcomes Reveal Impairments Not Explained by Psychophysical Testing in Patients With Regressed PDR.
Transl Vis Sci Technol. 2019 Jul 29;8(4):11. doi: 10.1167/tvst.8.4.11. eCollection 2019 Jul.
4
Diabetic Retinal Neurodegeneration-Should We Redefine Retinopathy From Diabetes?
JAMA Ophthalmol. 2019 Oct 1;137(10):1132-1133. doi: 10.1001/jamaophthalmol.2019.2536.
5
Portable Perimetry Using Eye-Tracking on a Tablet Computer-A Feasibility Assessment.
Transl Vis Sci Technol. 2019 Feb 5;8(1):17. doi: 10.1167/tvst.8.1.17. eCollection 2019 Jan.
7
Disorganization of Retinal Inner Layers (DRIL) and Neuroretinal Dysfunction in Early Diabetic Retinopathy.
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5481-5486. doi: 10.1167/iovs.18-24955.
10
Neurodegeneration in diabetic retinopathy: does it really matter?
Diabetologia. 2018 Sep;61(9):1902-1912. doi: 10.1007/s00125-018-4692-1. Epub 2018 Jul 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验